![]() |
|
![]() |
| Home | About and More Information | Transporter Data Index |
Synonyms: mdr, Mdr1, Pgy1, Abcb1, Mdr1b, Pgy-1
Entrez Gene Link
No expression data.
No substrate information.
| Inhibitor | IC50 (μM) | Ki (μM) | Substrate used | Cell System | Reference |
|---|---|---|---|---|---|
| Astemizole | 1.7 | Calcein AM | Mouse mdr1b expressing LLC-PK1 cells | Schwab, 2003 | |
| Cimetidine | >50 | Calcein AM | Mouse mdr1b expressing LLC-PK1 cells | Schwab, 2003 | |
| Clotrimazole | 3.5 | Calcein AM | Mouse mdr1b expressing LLC-PK1 cells | Schwab, 2003 | |
| Colchicine | >50 | Calcein AM | Mouse mdr1b expressing LLC-PK1 cells | Schwab, 2003 | |
| Cyclosporine | 0.7 | Calcein AM | Mouse mdr1b expressing LLC-PK1 cells | Schwab, 2003 | |
| Dexamethasone | >50 | Calcein AM | Mouse mdr1b expressing LLC-PK1 cells | Schwab, 2003 | |
| Digoxin | >50 | Calcein AM | Mouse mdr1b expressing LLC-PK1 cells | Schwab, 2003 | |
| DPDE (enkephalin) | >50 | Calcein AM | Mouse mdr1b expressing LLC-PK1 cells | Schwab, 2003 | |
| Erythromycin | >50 | Calcein AM | Mouse mdr1b expressing LLC-PK1 cells | Schwab, 2003 | |
| Etoposide | >50 | Calcein AM | Mouse mdr1b expressing LLC-PK1 cells | Schwab, 2003 | |
| Hydrocortisone | >50 | Calcein AM | Mouse mdr1b expressing LLC-PK1 cells | Schwab, 2003 | |
| Itraconazole | 0.7 | Calcein AM | Mouse mdr1b expressing LLC-PK1 cells | Schwab, 2003 | |
| Ivermectin | 0.5 | Calcein AM | Mouse mdr1b expressing LLC-PK1 cells | Schwab, 2003 | |
| Ketoconazole | 6.7 | Calcein AM | Mouse mdr1b expressing LLC-PK1 cells | Schwab, 2003 | |
| Mibefradil | 10 | Calcein AM | Mouse mdr1b expressing LLC-PK1 cells | Schwab, 2003 | |
| Miconazole | 2 | Calcein AM | Mouse mdr1b expressing LLC-PK1 cells | Schwab, 2003 | |
| Midazolam | 33 | Calcein AM | Mouse mdr1b expressing LLC-PK1 cells | Schwab, 2003 | |
| Morphine | >50 | Calcein AM | Mouse mdr1b expressing LLC-PK1 cells | Schwab, 2003 | |
| Nicardipine | 8 | Calcein AM | Mouse mdr1b expressing LLC-PK1 cells | Schwab, 2003 | |
| Pimozide | >50 | Calcein AM | Mouse mdr1b expressing LLC-PK1 cells | Schwab, 2003 | |
| Quinidine | 10 | Calcein AM | Mouse mdr1b expressing LLC-PK1 cells | Schwab, 2003 | |
| Ranitidine | >50 | Calcein AM | Mouse mdr1b expressing LLC-PK1 cells | Schwab, 2003 | |
| Ritonavir | >50 | Calcein AM | Mouse mdr1b expressing LLC-PK1 cells | Schwab, 2003 | |
| Saquinavir | >50 | Calcein AM | Mouse mdr1b expressing LLC-PK1 cells | Schwab, 2003 | |
| Terfenadine | 2 | Calcein AM | Mouse mdr1b expressing LLC-PK1 cells | Schwab, 2003 | |
| Verapamil | 2 | Calcein AM | Mouse mdr1b expressing LLC-PK1 cells | Schwab, 2003 | |
| Vinblastine | 8 | Calcein AM | Mouse mdr1b expressing LLC-PK1 cells | Schwab, 2003 |
ND = not determined
1 denotes drugs that can potentially be used as in vitro substrates for studies of the transporter as defined by the FDA as of March 2022
2 denotes drugs that can potentially be used as in vitro inhibitors for studies of the transporter as defined by the FDA as of March 2022
3 denotes drugs that can potentially be used as clinical substrates for studies of the transporter as defined by the FDA as of March 2022
4 denotes drugs that can potentially be used as clinical inhibitors for studies of the transporter as defined by the FDA as of March 2022
No drug-drug interaction information.